PubMed HealthSearch

PubMed · 7767479

[Development of a control method for sample distributors].

Abstract

The use in routine of distribution automations in Blood Bank laboratories should imply regular testing of the equipment by users. This work was carried out on Microlabs as well as on an IEMS. We used a coloured solution (Alizarine Red in pH9 buffer). We applied the Beer-Lambert law, knowing that any volume modification induces a change in optical density. After testing the linearity of the photometers used in the laboratory, we set up 4 distribution programmes so as to simulate classic distribution of diluted or undiluted serum: 1) for large volume dispensing, 2) for small volume distribution in a small amount of buffer, 3) for distribution of small volumes in large buffer volumes, 4) a specific IEMS programme. Results, expressed as coefficients of variation (CV) for each volume, varied from 9.8 to 0.7% according to the programme. These results show that large volume distribution does not pose any problem (CV < 5%). When dilution occurs, the error observed in serum distribution adds up to that of the thinner, and the smaller the two volumes, the greater is the error. It therefore appears necessary to find the best compromise between serum volume and thinner volume to obtain a CV < 5%. This error may appear negligible in semi-quantitative tests, but it may be important in quantitative tests. Lastly, this programme can easily be adapted in routine to monitor the dispensers efficiently.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Durand, B Annic, B Genetet. 1995. [Development of a control method for sample distributors].. https://doi.org/10.1016/s1246-7820(05)80005-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Assessing fluid and electrolyte status in the newborn. National Academy of Clinical Biochemistry.

Fluid and electrolyte assessment during the first week of life is complicated by rapid changes in fluid and electrolyte balance during the transition from fetal to neonatal life and by the newborn's small size. A physiologic decrease in extracellular water volume, as well as a transient increase in serum potassium and transient decreases in plasma glucose and total plasma ionized calcium concentrations must be taken into account. In general, the more immature the newborn, the greater the changes that can be expected. The use of plasma creatinine as an indicator of glomerular filtration rate is limited because it is a function of maternal renal function at birth and because of non-steady-state conditions in the immediate postnatal period. Guidelines for monitoring schedules are provided on the basis of these physiologic considerations and the author's experience. Method of blood sampling and time to separation of serum are important considerations in interpreting results. Minimization of sample volume is critical to minimize blood transfusion requirements. Clinicians should be aware of the analytical error associated with these measurements in their own institutions. Reference ranges are provided.

Blood Specimen Collection

Clinical evaluation of serial blood processing at point of care.

The Axial Separation Module (ASM), which separates whole-blood specimens serially in Axial Process Containers (APC), was evaluated for clinical performance at the University of Virginia Health Sciences Center (UVA HSC) in a community-based outpatient laboratory (North Ridge Clinic). We hypothesized that moving the task of blood separation to point of care would reduce specimen turnaround time within the main laboratory. Blood drawn into an APC was separated in the ASM at point of care at the North Ridge Clinic. Blood drawn into a Vacutainer Tube was separated in a conventional centrifuge at the main laboratory. Turnaround time was calculated for the "chem 17" test from files stored in our laboratory information system. Blood serially separated at point of care yielded turnaround time savings for specimens originating from the North Ridge Clinic. Average turnaround time decreased by 24%. Phlebotomists found no appreciable workload increase from incorporating the ASM as a point-of-care blood separation device. Phlebotomists also found that they could immediately detect hemolysis. We concluded that serial separation at point of care reduces specimen turnaround time at the main laboratory. The ASM/APC was found to be better suited for point-of-care blood separation than a conventional centrifuge. We speculate that immediate blood separation has the potential to improve the quality of analytical results.

Blood Specimen Collection

Blood stem cell transplantation: current concepts.

Mobilized peripheral blood haematopoietic progenitor cells are increasingly being used as against bone marrow (BM) transplants, following high dose chemotherapy and/or radiotherapy for the management of chemosensitive malignancies. Rapid haematopoietic reconstitution as evidenced by reduced duration of neutropaenia, fewer donor platelet infusions, shorter hospital stay and reduced cost of treatment are the advantages of this procedure. Reduced tumour cell contamination of mobilized blood compared to bone marrow however, has not been substantiated. Mobilization of lymphokine activated killer cells (LAK), use of blood stem cells (BSC) for allogeneic transplants and ex vivo expansion of the mobilized cells are emerging as the future areas for research. Addition of interleukin-3 (IL-3), stem cell factor (c-kit ligand) and PIXY-321 appear to open-up new vistas by enforcing trilineage and multilineage haematopoietic reconstitution.

Blood Specimen Collection